Familial idiopathic basal ganglia calcification (Fahr's disease)

Neurosciences

Volumn 19, Issue 3, 2014, Pages 171-177

  Mufaddel, Amir A ^a   Al Hassani, Ghanem A ^a  

^a AL AIN HOSPITAL   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM ANTAGONIST; CHELATING AGENT; TETRATHIOMOLYBDATE AMMONIUM;

AGGRESSION; ATAXIA; BASAL GANGLION; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CATATONIA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CORPUS STRIATUM; DELIRIUM; DELUSION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DYSARTHRIA; FAHR DISEASE; FAINTNESS; GLUCOSE METABOLISM; HALLUCINATION; HEADACHE; HUMAN; IRRITABILITY; MOOD DISORDER; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; ORTHOSTATIC HYPOTENSION; PARESIS; PARKINSONISM; PATHOGENESIS; PERSONALITY DISORDER; REVIEW; SEIZURE; SYMPTOMATOLOGY; TREMOR; VERTIGO; CALCINOSIS; DEGENERATIVE DISEASE; EXTRAPYRAMIDAL SYNDROME; PATHOLOGY; PATHOPHYSIOLOGY; SAUDI ARABIA;

BASAL GANGLIA; BASAL GANGLIA DISEASES; CALCINOSIS; HUMANS; NEURODEGENERATIVE DISEASES; SAUDI ARABIA;

EID: 84907873364     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Manyam BV. What is and what is not 'Fahr's disease'. Parkinsonism Relat Disord 2005; 11: 73-80.
2. Beall SS, Patten BM, Mallette L, Jankovic J. Abnormal systemic metabolism of iron, porphyrin, and calcium in Fahr's syndrome. Ann Neurol 1989; 26: 569-575.
3. Kobari M, Nogawa S, Sugimoto Y, Fukuuchi Y. Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology 1997; 48: 645-649.
4. Kim SH, Yoo BG, Kim KS, Yoo KM, Joh YD. Familial idiopathic striopallidodentate calcifications. J Korean Neurol Assoc 2003; 21: 191-194.
5. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 1999; 65: 764-772.
6. Yarlagadda A, Kaushik S, Clayton AH. Blood brain barrier: the role of calcium homeostasis. Psychiatry (Edgmont) 2007; 42: 55-59.
7. Malik R, Pandya VK, Naik D. Fahr disease-A rare neurodegenerative disorder. Indian Journal of Radiology and Imaging 2004; 14: 383-384.
8. Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 1992; 31: 379-384.
9. Hozumi I, Kohmura A, Kimura A, Hasegawa T, Honda A, Hayashi Y, et al. High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease. Case Rep Neurol 2010; 2: 46-51.
10. Uygur GA, Liu Y, Hellman RS, Tikofsky RS, Collier BD. Evaluation of regional cerebral blood flow in massive intracerebral calcifications. J Nucl Med 1995; 36: 610-702.
11. Benke T, Karner E, Seppi K, Delazer M, Marksteiner J, Donnemiller E. Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1163-1165.
12. Sobrido MJ, Coppola G, Oliveira J, Hopfer S, Geschwind DH. Primary Familial Brain Calcification. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, et al, editors. GeneReviews™ [Internet]. 2004 Apr 18 [Updated 2013 Jun 27]. Seattle (WA): University of Washington 1993-2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1421/
13. Bostan AC, Strick PL. The cerebellum and basal ganglia are interconnected. Neuropsychol Rev 2010; 20: 261-270.
14. Haber SN. Functional Anatomy and Physiology of the Basal Ganglia: Non-motor Functions. In: Tarsy D, Vitek JL, Starr PA, Okun MS, editors. Deep Brain Stimulation in Neurological and Psychiatric Disorders. Totowa (NJ): Humana Press; 2008. p. 33-62.
15. Ring HA, Serra-Mestres JS. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 2002; 72: 12-21.
16. Raunch SL, Savage CR. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatry Clin North Am 1997; 20: 741-768.
17. Schultz W, Tremblay L, Hollerman JR. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 1998; 37: 421-429.
18. Lauterbach EC, Cummings JL, Duffy J, Coffey CE, Kaufer D, Lovell M, et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 1998; 10: 249-266.
19. Abubakar SA, Saidu S. Idiopathic bilateral strio-pallido-dentate calcinosis (Fahr's disease): a case report and review of the literature. Ann Afr Med 2012; 11: 234-237.
20. Lazar M, Ion DA, Streinu-Cercel A, Badarau AI. Fahr's syndrome: diagnosis issues in patients with unknown family history of disease. Rom J Morphol Embryol 2009; 50: 425-428.
21. Trautner RJ, Cummings JL, Read SL, Benson DF. Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry 1988; 145: 350-353.
22. Shakibai SV, Johnson JP, Bourgeois JA. Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics 2005; 46: 569-572.
23. Srivastava S, Bhatia MS, Sharma V, Mahajan S, Rajender G. Fahr's Disease: An Incidental Finding in a Case Presenting with Psychosis. German Journal of Psychiatry 2010; 13: 86-90.
24. Kao YC, Lin MI. Intramuscular hemangioma of the temporalis muscle with incidental finding of bilateral symmetric calcification of the basal ganglia: a case report. Pediatr Neonatol 2010; 51: 296-299.
25. Konig P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry 1989; 25: 459-468.
26. Ghormode D, Maheshwari U, Kate N, Grover S. Fahr's disease and psychiatric syndromes: A case series. Ind Psychiatry J 2011; 20: 136-138.
27. Shoyama M, Kitabata Y, Kaku T, Shinosaki K. Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis: a case report. AJNR Am J Neuroradiol 2005; 26: 2527-2529.
28. Shibayama H, Kobayashi H, Nakagawa M, Yamada K, Iwata H, Iwai K, et al. Non-Alzheimer non-Pick dementia with Fahr's syndrome. Clin Neuropathol 1992; 11: 237-250.
29. Lam JS, Fong SY, Yiu GC, Wing YK. Fahr's disease: a differential diagnosis of frontal lobe syndrome. Hong Kong Med J 2007; 13: 75-77.
30. Massano J, Bhatia KP. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2012; 2: a008870.
31. Manyam BV, Walters AS, Naria KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 2001; 16: 258-264.
32. Alvarez MV, Evidente VG. Understanding drug-induced parkinsonism: separating pearls from oysters. Neurology 2008; 70: 32-34.
33. Manabe Y, Araki M, Takeda K, Yokota S, Kimura T. Pseudohypoparathyroidism with striopallidodentate calcification-a case report and review of the literature. Jpn J Med 1989; 28: 391-395.
34. Mufaddel A, Alsabousi M, Salih B, Alhassani G, Osman OT. A case of Gorling-Goltz syndrome presented with psychiatric features. Behav Neurol 2013 Aug 20. [Epub ahead of print]
35. Makariou E, Patsalides AD. Intracranial calcifications. Applied Radiology 2009; 38: 48-60.
36. Celzo FG, Venstermans C, De Belder F, Van Goethem J, van den Hauwe L, van der Zijden T, et al. Brain stones revisited-between a rock and a hard place. Insights Imaging 2013; 4: 625-635.
37. Skvortsov IA, Rudenskaia GE, Karaseva AN, Vel'tishchev IuE. [Effectiveness of therapeutic use of complexones in various diseases of the extrapyramidal system in children]. Zh Nevropatol Psikhiatr Im S S Korsakova 1987; 87: 1457-1462.